Salvage surgery for locally recurrent rectal cancer: Total mesorectal excision during the primary operation does not influence the outcome

Colorectal Disease

Volumn 13, Issue 5, 2011, Pages 506-511

  Wiig, J N ^a   Larsen, S G ^a   Dueland, S ^a   Flatmark, K ^a   Giercksky, K E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Local recurrence; Multimodal treatment; Rectal cancer; Surgery; Total mesorectal excision

Indexed keywords

FLUOROURACIL PLUS FOLINIC ACID; OXALIPLATIN; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; INTRAOPERATIVE RADIOTHERAPY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM SURGERY; RECURRENT CANCER; SALVAGE THERAPY; TOTAL MESORECTAL EXCISION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NORWAY; RADIATION-SENSITIZING AGENTS; RECTAL NEOPLASMS; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 79953329586     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02256.x     Document Type: Article

References (18)

1. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-82.
2. A, Moller B, Norstein J et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-66.
3. Cunningham JD, Enker W, Cohen A. Salvage therapy for pelvic recurrence following curative rectal cancer resection. Dis Colon Rectum 1997; 40: 393-400.
4. Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001; 44: 173-8.
5. Wiig JN, Larsen SG, Dueland S, Giercksky KE. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence. Colorectal Dis 2008; 10: 48-57.
6. Wibe A, Carlsen E, Dahl O et al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006; 8: 224-9.
7. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky K-E. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative irradiation (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002; 62: 207-13.
8. Hahnloser D, Nelson H, Gunderson LL et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237: 502-8.
9. Bozzetti F, Bertario L, Rossetti C et al. Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997; 40: 1421-4.
10. Bakx R, van TH, Van Lanschot JJ, Zoetmulder FA. Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol 2004; 30: 857-63.
11. Dresen RC, Gosens MJ, Martijn H et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15: 1937-47.
12. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974; 34: 1278-92.
13. Wiig JN, Larsen SG, Dueland S, Giercksky KE. Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 2005; 92: 70-5.
14. Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-94.
15. Wiig JN, Wolff PA, Tveit KM, Giercksky KE. Location of pelvic recurrence after 'curative' low anterior resection for rectal cancer. Eur J Surg Oncol 1999; 25: 590-4.
16. Wibe A, Rendedal PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-34.
17. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 447-54.
18. Park JK, Kim YW, Hur H et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg 2009; 394: 71-7.